A Toll-like Receptor-Activating, Self-Adjuvant Glycan Nanocarrier
Description
The global pandemic of COVID-19 highlights the importance of vaccination, which remains the most efficient measure against many diseases. Despite the progress in vaccine design, concerns with suboptimal antigen immunogenicity and delivery efficiency
